İlhan, A. Et Al. 2023. The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer. European Review for Medical and Pharmacological Sciences , vol.27, no.5 , 2060-2067.

İlhan, A., Gurler, F., Yilmaz, F., Eraslan, E., & Dogan, M., (2023). The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer. European Review for Medical and Pharmacological Sciences , vol.27, no.5, 2060-2067.

İlhan, Aysegul Et Al. "The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer," European Review for Medical and Pharmacological Sciences , vol.27, no.5, 2060-2067, 2023

İlhan, Aysegul Et Al. "The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer." European Review for Medical and Pharmacological Sciences , vol.27, no.5, pp.2060-2067, 2023

İlhan, A. Et Al. (2023) . "The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer." European Review for Medical and Pharmacological Sciences , vol.27, no.5, pp.2060-2067.

@article{article, author={Aysegul İlhan Et Al. }, title={The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer}, journal={European Review for Medical and Pharmacological Sciences}, year=2023, pages={2060-2067} }